(NASDAQ: NEPH) Nephros's forecast annual revenue growth rate of 3.03% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 3.89%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 21.75%.
Nephros's revenue in 2026 is $20,722,000.On average, 5 Wall Street analysts forecast NEPH's revenue for 2026 to be $231,863,562, with the lowest NEPH revenue forecast at $219,135,501, and the highest NEPH revenue forecast at $241,746,271.
In 2027, NEPH is forecast to generate $263,672,853 in revenue, with the lowest revenue forecast at $246,122,900 and the highest revenue forecast at $279,148,524.